Makoto Yamaguchi

Makoto Yamaguchi

Auto-generated profile, based on publicly available information

Makoto Yamaguchi

Division of Infectious Diseases, Aichi Cancer Center Hospital , Aichi

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
NINaoya Itoh
Naoya Itoh
NANana Akazawa-Kai
Nana Akazawa-Kai
MYMakoto Yamaguchi
Makoto Yamaguchi
TKTakanori Kawabata
Takanori Kawabata
Background: Patients with cancer are particularly susceptible to developing drug-resistant organisms due to the high frequency of infections during cancer treatment and the use of broad-spectrum antimicrobial agents. Therefore, patients with cancer are ideal candidates for an antimicrobial stewardship program (ASP); however, no established ASPs specifically target these patients. In this study, we evaluated the effect of a 46-month ASP intervention and infectious diseases consultation using a unique antimicrobial quality measure. Methods: Our single-center, retrospective, observational study was conducted from 1 April 2018 to 31 January 2024 and evaluated 2 phases: preintervention (antimicrobial notification by the infection control team) and postintervention (implementation of ASP and establishment of the infectious diseases consultation service). Results: The days of therapy (DOT) for 3 intravenous carbapenems significantly decreased, and the DOT of narrow-spectrum antimicrobials significantly increased after the intervention. A significant reduction was observed in the length of hospital stay, with no change in the incidence of hospital-acquired resistant microorganisms. All-cause in-hospital mortality rates and the 30-day mortality rate among patients with bacteremia episodes were numerically reduced, although not significantly, compared to the preintervention period. The rate of appropriate use of antimicrobial agents increased significantly during the late postintervention period (1 April 2021 to 31 January 2024). Conclusions: Our intervention was associated with the promotion of appropriate use of antimicrobial agents and a reduction in the length of hospital stay. These findings can help establish safer cancer treatments and improve patient prognosis.

28 March 2024 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
NINaoya Itoh
Naoya Itoh
NANana Akazawa
Nana Akazawa
MYMakoto Yamaguchi
Makoto Yamaguchi
YIYuichi Ishibana
Yuichi Ishibana
HMHiromi Murakami
Hiromi Murakami
NINaruhiko Ishiwada
Naruhiko Ishiwada